he immune response is able to control cytomegalovirus infection in most subjects. However, in some patient groups the virus is not well contained resulting in disease and severe morbidity. The development of efficacious vaccines is therefore a high priority. Antibodies may contribute to protection against disease caused by CMV but the most efficient targets for protective humoral immunity are not precisely known. Glycoprotein B (gB) is a protein that is targeted by virus-neutralizing antibodies. One epitope on gB, AD-2, is poorly immunogenic following natural infection and vaccination. It is consequently not effectively exploited as a target for antibodies by the immune system. However, antibodies specific for this epitope, when they develo...
Vaccination against human cytomegalovirus (CMV) infection remains high priority. A recombinant form ...
AbstractSite I of antigenic domain 2 (AD-2) on human cytomegalovirus glycoprotein B (gB) is poorly i...
Abstract Human Cytomegalovirus (HCMV) is the leading infectious congenital infection globally and th...
Antibodies provide some protection against cytomegalovirus-mediated disease. All aspects of antibody...
Glycoprotein B (gB) is a major component in several vaccines that are under development for preventi...
Human cytomegalovirus (HCMV), a herpesvirus, is a ubiquitously distributed pathogen that causes seve...
Glycoprotein B (gB) of human cytomegalovirus (HCMV) is the dominating protein in the envelope of thi...
<div><p>Human cytomegalovirus (HCMV) is an important, ubiquitous pathogen that causes severe clinica...
The capability of the antibody (Ab) repertoire to mount a response to appropriate epitopes on infect...
Human cytomegalovirus (HCMV) is an important, ubiquitous pathogen that causes severe clinical diseas...
A prophylactic vaccine to prevent the congenital transmission of human cytomegalovirus (HCMV) in new...
Glycoprotein B (gB, gpUL55) is the major antigen for the induction of neutralizing antibodies agains...
AbstractSite I of antigenic domain 2 (AD-2) on human cytomegalovirus glycoprotein B (gB) is poorly i...
Glycoprotein B (gB, gpUL55) is the major antigen for the induction of neutralizing antibodies agains...
Human cytomegalovirus (HCMV) remains an important cause of mortality in immune compromised transplan...
Vaccination against human cytomegalovirus (CMV) infection remains high priority. A recombinant form ...
AbstractSite I of antigenic domain 2 (AD-2) on human cytomegalovirus glycoprotein B (gB) is poorly i...
Abstract Human Cytomegalovirus (HCMV) is the leading infectious congenital infection globally and th...
Antibodies provide some protection against cytomegalovirus-mediated disease. All aspects of antibody...
Glycoprotein B (gB) is a major component in several vaccines that are under development for preventi...
Human cytomegalovirus (HCMV), a herpesvirus, is a ubiquitously distributed pathogen that causes seve...
Glycoprotein B (gB) of human cytomegalovirus (HCMV) is the dominating protein in the envelope of thi...
<div><p>Human cytomegalovirus (HCMV) is an important, ubiquitous pathogen that causes severe clinica...
The capability of the antibody (Ab) repertoire to mount a response to appropriate epitopes on infect...
Human cytomegalovirus (HCMV) is an important, ubiquitous pathogen that causes severe clinical diseas...
A prophylactic vaccine to prevent the congenital transmission of human cytomegalovirus (HCMV) in new...
Glycoprotein B (gB, gpUL55) is the major antigen for the induction of neutralizing antibodies agains...
AbstractSite I of antigenic domain 2 (AD-2) on human cytomegalovirus glycoprotein B (gB) is poorly i...
Glycoprotein B (gB, gpUL55) is the major antigen for the induction of neutralizing antibodies agains...
Human cytomegalovirus (HCMV) remains an important cause of mortality in immune compromised transplan...
Vaccination against human cytomegalovirus (CMV) infection remains high priority. A recombinant form ...
AbstractSite I of antigenic domain 2 (AD-2) on human cytomegalovirus glycoprotein B (gB) is poorly i...
Abstract Human Cytomegalovirus (HCMV) is the leading infectious congenital infection globally and th...